• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型稠合菲咯啉的设计、合成、分子模拟及抗癌活性研究。

Design, Synthesis, Molecular Modelling and Anticancer Activities of New Fused Phenanthrolines.

机构信息

Faculty of Chemistry, Alexandru Ioan Cuza University of Iasi, 11 Carol I, Iasi 700506, Romania.

出版信息

Molecules. 2020 Jan 25;25(3):527. doi: 10.3390/molecules25030527.

DOI:10.3390/molecules25030527
PMID:31991806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7036904/
Abstract

Three series of fused pyrrolophenanthroline derivatives were designed as analogues of phenstatin and synthesized in two steps starting with 1,7-phenanthroline, 4,7-phenanthroline and 1,10-phenanthroline, respectively. Two (Compounds and ) of the four compounds tested against a panel of sixty human cancer cell lines of the National Cancer Institute (NCI) exhibited significant growth inhibition activity on several cell lines. Compound showed a broad spectrum in terms of antiproliferative efficacy with GI values in the range of 0.296 to 250 μM. Molecular docking studies indicated that Compounds and are accommodated in the colchicine binding site of tubulin in two different ways.

摘要

设计了三个系列的稠合吡咯并菲咯啉衍生物作为苯并菲斯汀的类似物,分别以 1,7-菲咯啉、4,7-菲咯啉和 1,10-菲咯啉为起始原料,经两步法合成。在所测试的四种化合物中,有两种(化合物 和 )对国立癌症研究所(NCI)的六十个人类癌细胞系进行了测试,对几种细胞系表现出显著的生长抑制活性。化合物 在抗增殖功效方面表现出广谱性,GI 值范围为 0.296 至 250 μM。分子对接研究表明,化合物 和 以两种不同的方式容纳在微管蛋白的秋水仙碱结合位点中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc94/7036904/6af6c008e766/molecules-25-00527-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc94/7036904/91d796f1e230/molecules-25-00527-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc94/7036904/6ec8b6dc4259/molecules-25-00527-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc94/7036904/26b61f30edf1/molecules-25-00527-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc94/7036904/6af6c008e766/molecules-25-00527-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc94/7036904/91d796f1e230/molecules-25-00527-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc94/7036904/6ec8b6dc4259/molecules-25-00527-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc94/7036904/26b61f30edf1/molecules-25-00527-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc94/7036904/6af6c008e766/molecules-25-00527-g002.jpg

相似文献

1
Design, Synthesis, Molecular Modelling and Anticancer Activities of New Fused Phenanthrolines.新型稠合菲咯啉的设计、合成、分子模拟及抗癌活性研究。
Molecules. 2020 Jan 25;25(3):527. doi: 10.3390/molecules25030527.
2
Synthesis and biological evaluation of 4-aza-2,3-dihydropyridophenanthrolines as tubulin polymerization inhibitors.4-氮杂-2,3-二氢吡啶并菲咯啉作为微管蛋白聚合抑制剂的合成及生物学评价
Bioorg Med Chem Lett. 2014 Aug 1;24(15):3356-60. doi: 10.1016/j.bmcl.2014.05.096. Epub 2014 Jun 6.
3
Synthesis, Antiproliferative Activity and Molecular Docking Studies of Novel Doubly Modified Colchicine Amides and Sulfonamides as Anticancer Agents.新型双修饰秋水仙酰胺和磺酰胺类化合物的合成、抗增殖活性及分子对接研究及其作为抗癌药物。
Molecules. 2020 Apr 14;25(8):1789. doi: 10.3390/molecules25081789.
4
Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity.具有抗血管生成和抗增殖抗癌活性的吲唑衍生物的设计、合成、生物评价和动力学模拟。
Bioorg Chem. 2019 Feb;82:340-359. doi: 10.1016/j.bioorg.2018.10.071. Epub 2018 Nov 2.
5
Synthesis, structure, antimycobacterial and anticancer evaluation of new pyrrolo-phenanthroline derivatives.新型吡咯并菲咯啉衍生物的合成、结构、抗分枝杆菌及抗癌活性评价
J Enzyme Inhib Med Chem. 2016;31(3):470-80. doi: 10.3109/14756366.2015.1039530. Epub 2015 May 6.
6
Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.2-萘基反式二苯乙烯和氰基二苯乙烯作为抗癌剂的合成与评价
Anticancer Agents Med Chem. 2018;18(4):556-564. doi: 10.2174/1871521409666170412115703.
7
Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.新型吡唑并[3,4-d]嘧啶类化合物作为潜在的细胞毒剂:设计、合成、分子对接和 CDK2 抑制。
Anticancer Agents Med Chem. 2019;19(11):1368-1381. doi: 10.2174/1871520619666190417153350.
8
Synthesis, molecular modelling and anticancer evaluation of new pyrrolo[1,2-b]pyridazine and pyrrolo[2,1-a]phthalazine derivatives.新型吡咯并[1,2-b]哒嗪和吡咯并[2,1-a]酞嗪衍生物的合成、分子建模和抗癌评价。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):230-243. doi: 10.1080/14756366.2018.1550085.
9
Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.一系列作为抗微管蛋白剂的杂环反式氰基柔红霉素类似物的合成、抗癌活性及分子对接研究
Eur J Med Chem. 2015 Mar 6;92:212-20. doi: 10.1016/j.ejmech.2014.12.050. Epub 2014 Dec 29.
10
Efficient synthesis of novel 1,10 phenanthroline-substituted imidazolium salts: Exploring their anticancer applications.新型1,10-菲咯啉取代咪唑鎓盐的高效合成:探索其抗癌应用。
Eur J Med Chem. 2024 Nov 5;277:116775. doi: 10.1016/j.ejmech.2024.116775. Epub 2024 Aug 13.

引用本文的文献

1
Pyrrolo-Fused Phenanthridines as Potential Anticancer Agents: Synthesis, Prediction, and Biological Evaluation.吡咯并稠合菲啶类化合物作为潜在的抗癌剂:合成、预测及生物学评价
J Biochem Mol Toxicol. 2025 Sep;39(9):e70443. doi: 10.1002/jbt.70443.
2
Unlocking the potential of trifluoromethyl pyrrole derivatives in chronic wounds management: rapid synthesis, structural insights, and potent antimicrobial activity.释放三氟甲基吡咯衍生物在慢性伤口管理中的潜力:快速合成、结构解析及强效抗菌活性
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2513406. doi: 10.1080/14756366.2025.2513406. Epub 2025 Jun 11.
3
Revisiting Fused-Pyrrolo-1,10-Phenanthroline Derivatives: Novel Transformations and Stability Studies.

本文引用的文献

1
Synthesis, molecular modelling and anticancer evaluation of new pyrrolo[1,2-b]pyridazine and pyrrolo[2,1-a]phthalazine derivatives.新型吡咯并[1,2-b]哒嗪和吡咯并[2,1-a]酞嗪衍生物的合成、分子建模和抗癌评价。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):230-243. doi: 10.1080/14756366.2018.1550085.
2
Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance.鉴定和表征 SSE15206,一种微管解聚剂,可克服多药耐药性。
Sci Rep. 2018 Feb 19;8(1):3305. doi: 10.1038/s41598-018-21642-0.
3
Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures.
重新审视稠合吡咯并[1,10]菲咯啉衍生物:新型转化及稳定性研究
ChemistryOpen. 2025 Jul;14(7):e202400365. doi: 10.1002/open.202400365. Epub 2025 May 6.
4
Anticancer Potential of Azatetracyclic Derivatives: In Vitro Screening and Selective Cytotoxicity of Azide and Monobrominated Compounds.氮杂四环衍生物的抗癌潜力:叠氮化物和单溴化物的体外筛选及选择性细胞毒性
Molecules. 2025 Feb 5;30(3):702. doi: 10.3390/molecules30030702.
5
Novel 3-Sulfonamide Dual-Tail Pyrrol-2-one Bridged Molecules as Potent Human Carbonic Anhydrase Isoform Inhibitors: Design, Synthesis, Molecular Modeling Investigation, and Anticancer Activity in MeWo, SK-BR-3, and MG-63 Cell Lines.新型3-磺酰胺双尾吡咯-2-酮桥连分子作为有效的人碳酸酐酶同工酶抑制剂:设计、合成、分子模拟研究及在MeWo、SK-BR-3和MG-63细胞系中的抗癌活性
J Med Chem. 2025 Jan 23;68(2):1863-1882. doi: 10.1021/acs.jmedchem.4c02586. Epub 2025 Jan 10.
6
New Library of Iodo-Quinoline Derivatives Obtained by an Alternative Synthetic Pathway and Their Antimicrobial Activity.新型碘喹啉衍生物库的另类合成途径及其抗菌活性。
Molecules. 2024 Feb 7;29(4):772. doi: 10.3390/molecules29040772.
7
Synthetic Approaches to Novel Human Carbonic Anhydrase Isoform Inhibitors Based on Pyrrol-2-one Moiety.基于吡咯-2-酮部分的新型人碳酸酐酶同工酶抑制剂的合成方法。
J Med Chem. 2024 Feb 22;67(4):3018-3038. doi: 10.1021/acs.jmedchem.3c02190. Epub 2024 Feb 1.
8
Exploring Pyrrolo-Fused Heterocycles as Promising Anticancer Agents: An Integrated Synthetic, Biological, and Computational Approach.探索吡咯并稠合杂环作为有前景的抗癌剂:一种综合的合成、生物学和计算方法。
Pharmaceuticals (Basel). 2023 Jun 11;16(6):865. doi: 10.3390/ph16060865.
9
Exploring Pyrrolo-Phenanthrolines as Semiconductors for Potential Implementation in Organic Electronics.探索吡咯并菲咯啉作为有机电子学中潜在应用的半导体材料。
Materials (Basel). 2023 Apr 25;16(9):3366. doi: 10.3390/ma16093366.
10
A Review on the Synthesis of Fluorescent Five- and Six-Membered Ring Azaheterocycles.关于荧光五元和六元氮杂环的合成综述。
Molecules. 2022 Sep 25;27(19):6321. doi: 10.3390/molecules27196321.
靶向秋水仙碱结合位点的微管蛋白抑制剂:优势结构视角
Future Med Chem. 2017 Oct;9(15):1765-1794. doi: 10.4155/fmc-2017-0100. Epub 2017 Sep 20.
4
The high price of anticancer drugs: origins, implications, barriers, solutions.抗癌药物的高昂价格:起源、影响、障碍、解决方案。
Nat Rev Clin Oncol. 2017 Jun;14(6):381-390. doi: 10.1038/nrclinonc.2017.31. Epub 2017 Mar 14.
5
The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.含1,10-菲咯啉金属配合物的抗菌活性:在抗生素耐药时代作为替代疗法的潜力
Curr Top Med Chem. 2017;17(11):1280-1302. doi: 10.2174/1568026616666161003143333.
6
Binding of dihydroxynaphthyl aryl ketones to tubulin colchicine site inhibits microtubule assembly.二羟基萘基芳基酮与微管蛋白秋水仙碱位点的结合会抑制微管组装。
Biochem Biophys Res Commun. 2015 Oct 23;466(3):418-25. doi: 10.1016/j.bbrc.2015.09.041. Epub 2015 Sep 11.
7
Synthesis, structure, antimycobacterial and anticancer evaluation of new pyrrolo-phenanthroline derivatives.新型吡咯并菲咯啉衍生物的合成、结构、抗分枝杆菌及抗癌活性评价
J Enzyme Inhib Med Chem. 2016;31(3):470-80. doi: 10.3109/14756366.2015.1039530. Epub 2015 May 6.
8
New indolizines with phenanthroline skeleton: Synthesis, structure, antimycobacterial and anticancer evaluation.具有菲咯啉骨架的新型中氮茚:合成、结构、抗分枝杆菌及抗癌活性评价
Bioorg Med Chem. 2015 May 15;23(10):2318-27. doi: 10.1016/j.bmc.2015.03.077. Epub 2015 Apr 6.
9
Studies on indolizines. Evaluation of their biological properties as microtubule-interacting agents and as melanoma targeting compounds.中氮茚类化合物的研究。评估其作为微管相互作用剂和黑色素瘤靶向化合物的生物学特性。
Eur J Med Chem. 2015 Jan 7;89:115-27. doi: 10.1016/j.ejmech.2014.10.041. Epub 2014 Oct 16.
10
Recent developments in tubulin polymerization inhibitors: An overview.微管蛋白聚合抑制剂的最新进展:综述。
Eur J Med Chem. 2014 Nov 24;87:89-124. doi: 10.1016/j.ejmech.2014.09.051. Epub 2014 Sep 16.